Drs Drew, Victory, and McCullough™ on Paxlovid Rebound, Implications for Use in Ambulatory COVID-19

Dr Peter McCullough™, who has used all the available generic and EUA authorized drugs for ambulatory COVID-19 weighs in on Paxlovid with Dr Drew Pinsky and Kelly Victory in 2022. Paxlovid became available two years into the pandemic after McCullough had extensive experience with hydroxychloroquine and ivermectin. In May 2022, the CDC put a physician health advisory on Paxlovid warning doctors it prolonged the illness and invited SARS-CoV-2 rebound or a recurrent case of COVID-19 illness. No such rebound was seen with HCQ or IVM. Courtesy Ask Dr Drew August 19, 2022.